GGrantIndex
← Leaderboards

Tony Moody

Duke University

$69,123,925
Attributed
$69,123,925
Total exposure
1
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $12M · FY201925
$20M$15M$10M$5M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$69,123,925 · 1

By mechanism

N01$69,123,925 · 1

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Design

Research focus

DesignInnovationImmunityEvaluationUniversal Influenza VaccineInfluenza Virus VaccineVirusVaccine CandidateClinical ResearchVaccinesVaccine DesignImmunogenicityImmunologicsInfluenza Virus StrainVaccine DeliveryClinical TrialsIn VitroIn VivoReagentEfficacy Testing2019-NcovResearch ActivityVaccine DevelopmentCovid-19 Vaccine

Grant awards (15)

Collaborative Influenza Vaccine Innovation Centers (CIVICs)$7,993,900
N01 · FY2025 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center$2,528,056
N01 · FY2024 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center$2,528,056
N01 · FY2024 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center$2,528,056
N01 · FY2024 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center$2,528,056
N01 · FY2024 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center$10,693,906
N01 · FY2023 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center$10,146,052
N01 · FY2022 · AI · contact PI
CIVIC SARS-CoV-2 Research Activities$688,076
N01 · FY2022 · AI · contact PI
CIVIC SARS-CoV-2 Research Activities$688,075
N01 · FY2022 · AI · contact PI
CIVIC SARS-CoV-2 Research Activities$464,973
N01 · FY2022 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center$10,008,687
N01 · FY2021 · AI · contact PI
CIVIC SARS-CoV-2 Research Activities$1,141,458
N01 · FY2021 · AI · contact PI
CIVIC SARS-CoV-2 Research Activities$515,384
N01 · FY2021 · AI · contact PI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER$8,741,423
N01 · FY2020 · AI · contact PI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER$7,929,767
N01 · FY2019 · AI · contact PI